OUR TECHNOLOGY

A new architecture for multiparametric cardiovascular monitoring.

FORESEE is developing an ultra-thin, battery-free intravascular microsensing platform designed to acquire complementary physiological measurements and support more comprehensive cardiovascular monitoring.

FORESEE volume-conduction concept: an external unit applies current through tissue to an implant between electrodes.

Volume-conduction powering concept from FORESEE's existing technical material.

AN INTEGRATED SYSTEM

Three components. One connected monitoring platform.

01

Intravascular microsensor

Designed to acquire physiological information from within the cardiovascular system.

02

External unit

Provides wireless power and supports data acquisition and communication with the implant.

03

Digital monitoring application

Intended to present physiological information and support physician-directed monitoring.

Deployment: a separate delivery system

The platform also includes a delivery system designed to deploy the intravascular microsensor in a branch of the pulmonary artery. It is the means of implantation, rather than part of the daily home measurement routine.

COMPLEMENTARY PHYSIOLOGICAL INFORMATION

Four measurements. A broader physiological picture.

FORESEE's platform is designed to integrate complementary measurements within a single intravascular device. Each parameter contributes a different type of physiological information.

Pulmonary artery pressure

Hemodynamic information.

Intrathoracic impedance

Measurements sensitive to changes in thoracic fluid status.

Cardiac mechanics

Information about the heart's mechanical activity.

Temperature

Complementary physiological information.

WIRELESS POWER AND COMMUNICATION

Battery-free by design.

Power delivered through volume conduction

An external unit applies high-frequency current bursts through external electrodes. These currents flow through tissue by volume conduction and are picked up by electrodes at the ends of the elongated implant.

The implant rectifies the received currents to power its electronics. The architecture also supports bidirectional communication with the external unit [5].

An active electronic sensing platform

The volume-conduction approach is designed to operate without an implanted electrochemical battery or a conventional receiving coil. Powering and communication functions can be integrated with sensing electronics in an application-specific integrated circuit (ASIC).

ULTRA-THIN INTRAVASCULAR DESIGN

Advanced electronics in an ultra-thin implant.

Reducing reliance on bulky powering components supports the development of thin, elongated devices. Miniaturized integrated electronics are a foundation for FORESEE's intravascular microsensing platform.

Earlier eAXON intramuscular microstimulator and research X-ray showing an implant with external textile electrodes; not the FORESEE cardiovascular device.

Earlier eAXON research: an intramuscular microstimulator, not the FORESEE cardiovascular device [5].

Building on earlier implantable-device research

The earlier eAXON devices used a hermetic capsule housing an integrated circuit within a flexible, elongated body. This research provides context for the powering and integration approach; it does not establish the dimensions, materials or validation status of the FORESEE cardiovascular implant.

DESIGNED FOR EVERYDAY USE

A simple daily routine. Comprehensive physiological information.

The target routine is an approximately five-minute measurement at home. This intended workflow and physician-directed patient self-management model are under development, not an already validated clinical service.

01

External unit

The patient uses the external unit as part of the intended home measurement routine.

02

Wireless powering

The external unit delivers wireless power to the implant through volume conduction.

03

Physiological acquisition

The powered implant acquires physiological measurements and communicates with the external unit.

04

Digital monitoring

Information becomes available through the digital monitoring system to support a physician-defined care plan.

BEYOND SINGLE-PARAMETER SYSTEMS

Multiparametric sensing starts with the architecture.

Single-parameter implantable monitoring focuses on one physiological signal. FORESEE's active sensing architecture is designed to bring multiple complementary measurements together within a single battery-free intravascular device.

Active multiparametric sensing

Designed to integrate complementary physiological measurements within one active electronic platform.

Battery-free wireless operation

Volume-conduction powering and communication without an implanted battery or conventional receiving coil.

Miniaturized intravascular design

An architecture intended to reduce the internal footprint of powering and electronic components.

Potential for scalable workflows

Intended to support structured home measurements and physician-directed monitoring; workload and clinical benefits remain to be evaluated.

FROM RESEARCH TO CLINICAL TRANSLATION

Advancing toward clinical evaluation.

FORESEE is progressing through prototype development and preclinical validation. Its cardiovascular platform is under development and is not presented as an approved or commercially available device.

FORESEE is a spin-off of Universitat Pompeu Fabra (UPF). Its work builds on research in bioelectrical phenomena and wireless powering of implantable devices.

Intellectual property

2

Patent families

Protecting FORESEE's core technology

1

Granted European patent

EP4052643B1

Research foundations and related patent documents

[5] J Neural Eng. 2022 Sep 14;19(5). Read publication.
[6] IEEE Trans Biomed Eng. 2023 Feb;70(2):659–670. Read publication.
[7] J Neuroeng Rehabil. 2024 Jan 3;21(1):4. Read publication.

These publications concern foundational research and earlier implantable technologies; they should not be interpreted as clinical validation of the FORESEE cardiovascular platform.

Patent family 1: EP3788948A1
Patent family 2: EP4052643B1

Interested in FORESEE's technology?

We welcome conversations with clinical, technological, and investment partners interested in advancing cardiovascular monitoring.

Contact Us